SYMPAZAN
Peakclobazam
NDAORALFILM
Approved
Nov 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
Cytochrome P450 2D6 Inhibitors
Pharmacologic Class:
Benzodiazepine
Clinical Trials (2)
An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
Started Mar 2016
18 enrolled
Epilepsy
A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
Started Jan 2016
20 enrolled
Epilepsy
Loss of Exclusivity
LOE Date
Jan 31, 2040
169 months away
Patent Expiry
Jan 31, 2040